Our industry experts understand the challenges and rigorous demands of pharmaceutical name development. We make it our mission to stay up-to-date on the latest regulations and approval requirements.
We utilize this knowledge to effectively address the complex issues your pharmaceutical brand faces – issues such as patient safety concerns; FDA, EMA and Health Canada regulations, and global trademark development. Our expertise spans domestic and international markets, pharmaceutical brand naming as well as USAN and INN naming.
Addison Whitney delivers pharmaceutical brands that integrate creativity, business strategy, trademark viability and regulatory compliance. We take pride in our reputation for consistently helping clients achieve approval for pharmaceutical names that meet all of their brand objectives.
« BACK TO VERBAL BRANDING
Gilead Sciences is a biopharmaceutical company ... LEARN MORE »
Bristol-Myers Squibb manufactures prescription ... LEARN MORE »
GlaxoSmithKline is a global healthcare group ... LEARN MORE »